Proxima Bio
A biotechnology company developing cell surface degraders to target previously undruggable proteins, with potential applications in autoimmune diseases and cancers.
Employees
Enterprise value
$4—6m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | AUD1.7m | Early VC | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads